Molecular diagnosis and management of hereditary angioedema in a Greek family

International Archives of Allergy and Immunology

Volumn 147, Issue 2, 2008, Pages 166-170

  Papadopoulou Alataki, Efimia ^a   Foerster, Tanja ^c   Antari, Vasiliki ^a   Pavlitou Tsiontsi, Aikaterini ^b   Varlamis, Georgios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b First Surgical Department   (Greece)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

C1 inhibitor concentrate; C1 inhibitor deficiency; Hereditary angioedema; Mutation

Indexed keywords

BERINERT P; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4 BINDING PROTEIN; DANAZOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; FEMALE; GENE MUTATION; HOSPITALIZATION; HUMAN; LABORATORY TEST; LARYNX EDEMA; MALE; MISSENSE MUTATION; PEDIGREE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCHOOL CHILD; SKIN SWELLING; SUBSTITUTION THERAPY; ULTRASOUND;

ADOLESCENT; ADULT; ANGIOEDEMA, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FAMILY; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 51849141005     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137286     Document Type: Article

References (20)

1. Bork K, Meng G, Staubach P, Hardt J: Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-274.
2. Cugno M, Nussberger J, Cicardi M, Agostoni A: Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003;3:311-317.
3. Davis AE: The pathogenesis of hereditary angioedema. Transfus Apher Sci 2003;29:195-203.
4. Bork K, Barnstedt SE, Koch P, Traupe H: Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000;356:213-217.
5. Drouet C, Cicardi M, Pappalardo E, Monnier N, Roche O, Tordai A, Wagenaar-Bos I, Pericone R, Bygum A, Bork K, Tosi M, Lopez-Trascasa M: New mutations of C1 inhibitor (SERPING1/C1NH) gene associated with hereditary angioedema in a European population. J Allergy Clin Immunol 2007;119:S277.
6. Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, et al: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. Immunol 2004;114:51-131.
7. Caballero T, Bouillet L, Bork K, Bucher C, Bygum A, DeCaroli C, Farkart H, Longhurst H, Nielsen E, Perricone R, Prior N, Cicardi M : European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT. Immunol 2007;119:S12.
8. Khan S, Tarzi MD, Doré PC, Sewell WAC, Longhurst HJ: Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin Immunol 2007;123:14-17.
9. Rusicke E, Martinez-Saguer I, Aygören-Pürsün E, Klingebiel T, Kreuz W: Intraindividual and interindividual variations of symptoms in patients with hereditary angioedema. J Allergy Clin Immunol 2007;119:S312.
10. Bork K, Ressel N: Sudden upper airway obstruction in patients with hereditary angioedema. Transfus Apher Sci 2003;29:235-238.
11. Bulnes M: Clinical evaluation of tolerance and viral safety of human c1-inhibitor concentrate in patients with recurrent angioedema due to hereditary (HAE) or acquired (AAE) C1 inhibitor deficiency. J Allergy Clin Immunol 2006;117:S121.
12. Serres J, Gröner A, Lindner J: Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review. Transfus Apher Sci 2003;29:247-254.
13. Davis AE: The pathophysiology of hereditary angioedema. Clin Immunol 2005;114:3-9.
14. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007;119: 1497-1503.
15. Levy RJ, Goodman S: Icatibant, a potent and selective bradykinin B2 receptor antagonist, is effective in treating patients with hereditary angioedema (HAE). J Allergy Clin Immunol 2007;119:S277.
16. Cicardi M, Zingale L, Zanichelli A, Lambertenghi Deliliers D: Established and new treatments for hereditary angioedema: an update. Mol Immunol 2007;44:3858-3861.
17. Kalmar L, Hegedus T, Farkas H, Nagy M, Tordai A: HAEdb: a novel interactive, locus specific mutation database for the C1 inhibitor gene. Hum Mutat 2005;25:1-5.
18. Foerster T: Molekulargenetik des Hereditären Angioödems; thesis, Wuerzburg, 2006. http://www.opus-bayern.de/uni-wuerzburg/volltexte/2006/ 2034/pdf/Doktorarbeit_finale_version.pdf.
19. Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M: Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angioedema. Am J Hum Genet 1996;59:308-319.
20. Zuraw BL, Herschbach J: Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 2000;105:541-546.